Jacques Himber
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 4
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 11
- Platelet Disorders and Treatments 3
- Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
- Immunology and Allergy top 5%
-
- Atrial Fibrillation Management and Outcomes 3
-
- Plant biochemistry and biosynthesis 3
- Metabolomics and Mass Spectrometry Studies 2
-
- Glaucoma and retinal disorders 3
- Co-authors
- Markus A. RiedererYale NemersonJuan J. BadimónBernd BohrmannUrsula RauchJohn T. FallonDiana BondermanDorothée Kling
- Cited by
- Internal MedicineHematologyGenetics
- Partner nations
- SwitzerlandUnited StatesChina
In The Last Decade
Jacques Himber
29 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Internal Medicine 423
- Hematology 1.1k
- Genetics 260
- Immunology and Allergy 113
- Cardiology and Cardiovascular Medicine 330
Countries citing papers authored by Jacques Himber
This map shows the geographic impact of Jacques Himber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Himber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Himber more than expected).
Fields of papers citing papers by Jacques Himber
This network shows the impact of papers produced by Jacques Himber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Himber. The network helps show where Jacques Himber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques Himber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 31 | |
| 2 | 2009 | 31 | |
| 3 | 2006 | 21 | |
| 4 | 2005 | 21 | |
| 5 | 2003 | 69 | |
| 6 | 2002 | 18 | |
| 7 | 2000 | 330 | |
| 8 | 1997 | 62 | |
| 9 | Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop ultracentrifuge. | 1995 | 26 |
| 10 | 1994 | 5 | |
| 11 | 1994 | 3 | |
| 12 | 1993 | 3 | |
| 13 | 1991 | 7 | |
| 14 | 1989 | 8 | |
| 15 | 1989 | 54 | |
| 16 | Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control. | 1989 | 5 |
| 17 | 1988 | 13 | |
| 18 | 1988 | 15 | |
| 19 | 1987 | 12 | |
| 20 | In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea. | 1985 | 5 |
About Jacques Himber
Jacques Himber is a scholar working on Internal Medicine, Hematology and Biochemistry, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Platelet Disorders and Treatments (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Plant biochemistry and biosynthesis (3 papers), Glaucoma and retinal disorders (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Internal Medicine (423 citations), Hematology (1.1k citations) and Genetics (260 citations). Jacques Himber has collaborated with scholars based in Switzerland, United States and China. Frequent co-authors include Markus A. Riederer, Yale Nemerson, Juan J. Badimón, Bernd Bohrmann, Ursula Rauch, John T. Fallon, Diana Bonderman, Dorothée Kling, Mercè Roqué and Peter L.A. Giesen. Their work appears in journals such as Blood, Atherosclerosis, Thrombosis and Haemostasis, Journal of Lipid Research and Journal of Ocular Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.